Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance

Journal of the American College of Cardiology

Volumn 59, Issue 17, 2012, Pages 1551-1560

  Baker, Aaron B ^a   Gibson, William J ^b   Kolachalama, Vijaya B ^b   Golomb, Mordechai ^b   Indolfi, Laura ^b   Spruell, Christopher ^a   Zcharia, Eyal ^c   Vlodavsky, Israel ^c   Edelman, Elazer R ^b,d  

^a The University of Texas at Austin   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

computational modeling; endovascular stenting; heparanase; thrombosis; vascular injury

Indexed keywords

HEPARANASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY THROMBOSIS; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; EX VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; STENT; STENT INDUCED FLOW DISTURBANCE; STENT THROMBOSIS; THROMBOGENESIS; THROMBOGENICITY;

ANGIOPLASTY, BALLOON; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CORONARY THROMBOSIS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GLUCURONIDASE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MULTIVARIATE ANALYSIS; RANDOM ALLOCATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STENTS; VASCULAR SYSTEM INJURIES;

EID: 84859843550     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.11.057     Document Type: Article

References (49)

1. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
2. J. Daemen, P. Wenaweser, K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678 (Pubitemid 46281313)
3. I. Vlodavsky, O. Goldshmidt, E. Zcharia Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development Semin Cancer Biol 12 2002 121 129 (Pubitemid 34680741)
4. U. Hacker, K. Nybakken, N. Perrimon Heparan sulphate proteoglycans: the sweet side of development Nat Rev Mol Cell Biol 6 2005 530 541 (Pubitemid 40943044)
5. J.A. Marcum, R.D. Rosenberg Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells Biochem Biophys Res Commun 126 1985 365 372 (Pubitemid 15173570)
6. L. Thunberg, G. Backstrom, U. Lindahl Further characterization of the antithrombin-binding sequence in heparin Carbohydr Res 100 1982 393 410
7. A.B. Baker, A. Groothuis, M. Jonas Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice Circ Res 104 2009 380 387
8. A. Katz, D.J. Van-Dijk, H. Aingorn Involvement of human heparanase in the pathogenesis of diabetic nephropathy Isr Med Assoc J 4 2002 996 1002
9. N. Ilan, M. Elkin, I. Vlodavsky Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis Int J Biochem Cell Biol 38 2006 2018 2039 (Pubitemid 44397619)
10. E. Edovitsky, I. Lerner, E. Zcharia, T. Peretz, I. Vlodavsky, M. Elkin Role of endothelial heparanase in delayed-type hypersensitivity Blood 107 2006 3609 3616
11. M. Waterman, O. Ben-Izhak, R. Eliakim, G. Groisman, I. Vlodavsky, N. Ilan Heparanase upregulation by colonic epithelium in inflammatory bowel disease Mod Pathol 20 2007 8 14 (Pubitemid 44967944)
12. E. Zcharia, S. Metzger, T. Chajek-Shaul Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior FASEB J 18 2004 252 263 (Pubitemid 38186244)
13. K. Kolandaivelu, E.R. Edelman Low background, pulsatile, in vitro flow circuit for modeling coronary implant thrombosis J Biomech Eng 124 2002 662 668 (Pubitemid 36119872)
14. C. Beythien, W. Terres, C.W. Hamm In vitro model to test the thrombogenicity of coronary stents Thromb Res 75 1994 581 590 (Pubitemid 24292008)
15. N. Duraiswamy, J.M. Cesar, R.T. Schoephoerster, J.E. Moore Jr. Effects of stent geometry on local flow dynamics and resulting platelet deposition in an in vitro model Biorheology 45 2008 547 561
16. C. Rogers, E.R. Edelman Endovascular stent design dictates experimental restenosis and thrombosis Circulation 91 1995 2995 3001
17. B. Balakrishnan, A.R. Tzafriri, P. Seifert, A. Groothuis, C. Rogers, E.R. Edelman Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents Circulation 111 2005 2958 2965 (Pubitemid 40814189)
18. C.W. Hwang, D. Wu, E.R. Edelman Impact of transport and drug properties on the local pharmacology of drug-eluting stents Int J Cardiovasc Intervent 5 2003 7 12 (Pubitemid 36227309)
19. M.A. Nugent, H.M. Nugent, R.V. Iozzo, K. Sanchack, E.R. Edelman Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia Proc Natl Acad Sci U S A 97 2000 6722 6727 (Pubitemid 30412781)
20. Y. Nadir, B. Brenner, A. Zetser Heparanase induces tissue factor expression in vascular endothelial and cancer cells J Thromb Haemost 4 2006 2443 2451 (Pubitemid 44575440)
21. Y. Nadir, B. Brenner, S. Gingis-Velitski Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells Thromb Haemost 99 2008 133 141
22. Y. Nadir, I. Vlodavsky, B. Brenner Heparanase, tissue factor, and cancer Semin Thromb Hemost 34 2008 187 194
23. Y. Nadir, B. Brenner Heparanase procoagulant effects and inhibition by heparins Thromb Res 125 Suppl 2 2010 S72 S76
24. B.Z. Katz, L. Muhl, E. Zwang Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms Thromb Haemost 98 2007 1193 1199 (Pubitemid 350239089)
25. Y. Nadir, B. Brenner, L. Fux, I. Shafat, J. Attias, I. Vlodavsky Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII Haematologica 95 2010 1927 1934
26. I. Vlodavsky, N. Ilan, Y. Nadir Heparanase, heparin and the coagulation system in cancer progression Thromb Res 120 Suppl 2 2007 S112 S120
27. J.D. Olson, A. Zaleski, D. Herrmann, P.A. Flood Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin J Lab Clin Med 114 1989 6 18 (Pubitemid 19187539)
28. L. De Marco, A. Girolami, S. Russell, Z.M. Ruggeri Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation J Clin Invest 75 1985 1198 1203 (Pubitemid 15087146)
29. Y. Ikeda, M. Handa, K. Kawano The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress J Clin Invest 87 1991 1234 1240
30. D.M. Peterson, N.A. Stathopoulos, T.D. Giorgio, J.D. Hellums, J.L. Moake Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa Blood 69 1987 625 628 (Pubitemid 17022038)
31. L.F. Poletti, K.E. Bird, D. Marques, R.B. Harris, Y. Suda, M. Sobel Structural aspects of heparin responsible for interactions with von Willebrand factor Arterioscler Thromb Vasc Biol 17 1997 925 931 (Pubitemid 27209271)
32. A.G. Sarafanov, N.M. Ananyeva, M. Shima, E.L. Saenko Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein J Biol Chem 276 2001 11970 11979
33. K. Mahtouk, D. Hose, P. Raynaud Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma Blood 109 2007 4914 4923 (Pubitemid 46827789)
34. Y. Yang, V. Macleod, H.Q. Miao Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis J Biol Chem 282 2007 13326 13333 (Pubitemid 47100527)
35. I. Shafat, A.B. Barak, S. Postovsky Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment Neoplasia 9 2007 909 916 (Pubitemid 350086436)
36. R.W. Li, C. Freeman, D. Yu Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis Arthritis Rheum 58 2008 1590 1600 (Pubitemid 351847512)
37. M.J. van den Hoven, A.L. Rops, I. Vlodavsky, V. Levidiotis, J.H. Berden, J. van der Vlag Heparanase in glomerular diseases Kidney Int 72 2007 543 548 (Pubitemid 47312787)
38. I. Vlodavsky, A. Eldor, A. Haimovitz-Friedman Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation Invasion Metastasis 12 1992 112 127
39. E. Zcharia, R. Zilka, A. Yaar Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models FASEB J 19 2005 211 221 (Pubitemid 40192578)
40. I. Iakovou, T. Schmidt, E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
41. E.D. Rosen, S. Raymond, A. Zollman Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi Am J Pathol 158 2001 1613 1622 (Pubitemid 32422926)
42. J. Hallgren, D. Spillmann, G. Pejler Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin J Biol Chem 276 2001 42774 42781
43. J.I. Weitz Heparan sulfate: antithrombotic or not? J Clin Invest 111 2003 952 954 (Pubitemid 36397470)
44. S. HajMohammadi, K. Enjyoji, M. Princivalle Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis J Clin Invest 111 2003 989 999 (Pubitemid 36397475)
45. F. Gong, P. Jemth, M.L. Escobar Galvis Processing of macromolecular heparin by heparanase J Biol Chem 278 2003 35152 35158 (Pubitemid 37102279)
46. A.B. Baker, Y.S. Chatzizisis, R. Beigel Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine Atherosclerosis 213 2010 436 442
47. I. Shafat, N. Ilan, S. Zoabi, I. Vlodavsky, F. Nakhoul Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levels PloS One 6 2011 e17312
48. I. Vlodavsky, P. Beckhove, I. Lerner Significance of heparanase in cancer and inflammation Cancer Microenviron 2011 Aug 3 [E-pub ahead of print]
49. A.R. Hobson, D.B. McKenzie, V. Kunadian Malignancy: an unrecognized risk factor for coronary stent thrombosis? J Invasive Cardiol 20 2008 E120 E123